{"id":690826,"date":"2022-09-30T16:03:16","date_gmt":"2022-09-30T20:03:16","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\/"},"modified":"2022-09-30T16:03:16","modified_gmt":"2022-09-30T20:03:16","slug":"total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\/","title":{"rendered":"Total number of shares and voting rights in Zealand Pharma at September 30, 2022"},"content":{"rendered":"<div class=\"mw_release\">\n<p>Company announcement \u2013 No. 42\u00a0\/ 2022<\/p>\n<p>\n        <strong>Total number of shares and voting rights in Zealand Pharma at <\/strong><br \/>\n        <strong>September<\/strong><br \/>\n        <strong> 3<\/strong><br \/>\n        <strong>0<\/strong><br \/>\n        <strong>, <\/strong><br \/>\n        <strong>20<\/strong><br \/>\n        <strong>22<\/strong>\n      <\/p>\n<p>\n        <strong><br \/>\n          <em>Copenhagen,<\/em><br \/>\n        <\/strong><br \/>\n        <strong><br \/>\n          <em> DK and Boston, MA,<\/em><br \/>\n        <\/strong><br \/>\n        <strong><br \/>\n          <em>September 30<\/em><br \/>\n        <\/strong><br \/>\n        <strong><br \/>\n          <em>, 20<\/em><br \/>\n        <\/strong><br \/>\n        <strong><br \/>\n          <em>2<\/em><br \/>\n        <\/strong><br \/>\n        <strong><br \/>\n          <em>2<\/em><br \/>\n        <\/strong><br \/>\n        <em>\u2013<\/em> Zealand Pharma A\/S (\u201cZealand\u201d) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company at the end of a calendar month during which there have been changes to its share capital.<\/p>\n<p>In Company announcement No. 39\/2022 from September 13, 2022, Zealand announced an increase in share capital relating to exercise of employee warrants. Following this announcement, the table below lists the total number of shares and voting rights in Zealand up to and including September 30, 2022.<\/p>\n<table style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;border-collapse: collapse;margin-left:0;border-collapse:collapse\">\n<tr>\n<td style=\"width:144px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">\n<p>            <strong>Date<\/strong>\n          <\/td>\n<td style=\"width:198px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Number of shares<\/strong><br \/>\n            <br \/>\n            <strong>(nominal value of DKK 1 each)<\/strong>\n          <\/td>\n<td style=\"width:168px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Share capital<\/strong><br \/>\n            <br \/>\n            <strong>(nominal value in DKK)<\/strong>\n          <\/td>\n<td style=\"width:132.2px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Number of voting rights<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:144px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">August 31, 2022<\/td>\n<td style=\"width:198px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">46,538,186<\/td>\n<td style=\"width:168px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">46,538,186<\/td>\n<td style=\"width:132.2px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">46,538,186<\/td>\n<\/tr>\n<\/table>\n<p align=\"center\">\n        <strong># # #<\/strong>\n      <\/p>\n<p>\n        <strong>About Zealand Pharma A\/S<\/strong>\n      <\/p>\n<p>Zealand Pharma A\/S (Nasdaq: ZEAL) (&#8220;Zealand&#8221;) is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. In addition, license collaborations with Boehringer Ingelheim and AstraZeneca create opportunities for more patients to potentially benefit from Zealand-invented peptide investigational agents currently in development.<br \/>Zealand was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the U.S. that includes Boston. For more information about Zealand\u2019s business and activities, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1C2k4XwJbWlA6Vy1TW01Aqfvn8FwnGvV2uzSyQKHyK5QMhU_B9nKVTilNMcyoxFm-bQ-c7hozS3-pWKZ3x_mvdNVNxJeCJLiNbsMd_2NfgCbUKulIYzX4zJpL06QgQMUkQ78F8WaTl1XnrVz9LVDnqGqK7_91jLw4W7-PvEZpIX8RxH2rb0_Y1MgQZG_yzznA2mL5ChDidXQtZYjZD3-wG6bXxoYfrwhXNYcxJj_qFpcTs46Chg1y3iP6JEVZp5MzOr8AUILNwNH1YQUNbdxCQ==\" rel=\"nofollow noopener\" target=\"_blank\">www.zealandpharma.com<\/a>.<\/p>\n<p>\n        <strong>Forward-Looking Statement<\/strong><\/p>\n<p>The above information contains forward-looking statements that provide Zealand Pharma\u2019s expectations or forecasts of future events, including forward-looking statements about the termination of the Company\u2019s ADR program. Such forward-looking statements are subject to risks, uncertainties and inaccurate assumptions, which may cause actual results to differ materially from expectations set forth herein and may cause any or all of such forward-looking statements to be incorrect. If any or all of such forward-looking statements prove to be incorrect, our actual results could differ materially and adversely from those anticipated or implied by such statements. All such forward-looking statements speak only as of the date of this release and are based on information available to Zealand Pharma as of the date of this release. Except as required by law, the Company assumes no obligation to update these forward-looking statements publicly.<\/p>\n<p>\n        <strong>C<\/strong><br \/>\n        <strong>ontact:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;border-collapse:collapse\">\n<tr>\n<td style=\"width:0px;vertical-align: middle\">Anna Krassowska, PhD<br \/>Vice President, Investor Relations &amp; Corporate Communications<br \/>Zealand Pharma<br \/>Email: ank@zealandpharma.com<\/p>\n<p>David Rosen (U.S. Media)<br \/>Argot Partners<br \/>Email: media@zealandpharma.com\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width:0px;vertical-align: middle\">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc0ODQyNiM0MDEzOTQ2MjUjMjAwMTcwMQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/NjQ1MTBlMDEtZDk1Zi00ZWZlLWIzMzgtZTUyZGI4YWY5Y2FmLTEwMTMyNzQ=\/tiny\/Zealand-Pharma.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Company announcement \u2013 No. 42\u00a0\/ 2022 Total number of shares and voting rights in Zealand Pharma at September 3 0 , 20 22 Copenhagen, DK and Boston, MA, September 30 , 20 2 2 \u2013 Zealand Pharma A\/S (\u201cZealand\u201d) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company at the end of a calendar month during which there have been changes to its share capital. In Company announcement No. 39\/2022 from September 13, 2022, Zealand announced an increase in share capital relating to exercise of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Total number of shares and voting rights in Zealand Pharma at September 30, 2022&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-690826","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Total number of shares and voting rights in Zealand Pharma at September 30, 2022 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Total number of shares and voting rights in Zealand Pharma at September 30, 2022 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Company announcement \u2013 No. 42\u00a0\/ 2022 Total number of shares and voting rights in Zealand Pharma at September 3 0 , 20 22 Copenhagen, DK and Boston, MA, September 30 , 20 2 2 \u2013 Zealand Pharma A\/S (\u201cZealand\u201d) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company at the end of a calendar month during which there have been changes to its share capital. In Company announcement No. 39\/2022 from September 13, 2022, Zealand announced an increase in share capital relating to exercise of &hellip; Continue reading &quot;Total number of shares and voting rights in Zealand Pharma at September 30, 2022&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-30T20:03:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc0ODQyNiM0MDEzOTQ2MjUjMjAwMTcwMQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Total number of shares and voting rights in Zealand Pharma at September 30, 2022\",\"datePublished\":\"2022-09-30T20:03:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\\\/\"},\"wordCount\":431,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDc0ODQyNiM0MDEzOTQ2MjUjMjAwMTcwMQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\\\/\",\"name\":\"Total number of shares and voting rights in Zealand Pharma at September 30, 2022 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDc0ODQyNiM0MDEzOTQ2MjUjMjAwMTcwMQ==\",\"datePublished\":\"2022-09-30T20:03:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDc0ODQyNiM0MDEzOTQ2MjUjMjAwMTcwMQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDc0ODQyNiM0MDEzOTQ2MjUjMjAwMTcwMQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Total number of shares and voting rights in Zealand Pharma at September 30, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Total number of shares and voting rights in Zealand Pharma at September 30, 2022 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\/","og_locale":"en_US","og_type":"article","og_title":"Total number of shares and voting rights in Zealand Pharma at September 30, 2022 - Market Newsdesk","og_description":"Company announcement \u2013 No. 42\u00a0\/ 2022 Total number of shares and voting rights in Zealand Pharma at September 3 0 , 20 22 Copenhagen, DK and Boston, MA, September 30 , 20 2 2 \u2013 Zealand Pharma A\/S (\u201cZealand\u201d) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company at the end of a calendar month during which there have been changes to its share capital. In Company announcement No. 39\/2022 from September 13, 2022, Zealand announced an increase in share capital relating to exercise of &hellip; Continue reading \"Total number of shares and voting rights in Zealand Pharma at September 30, 2022\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-30T20:03:16+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc0ODQyNiM0MDEzOTQ2MjUjMjAwMTcwMQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Total number of shares and voting rights in Zealand Pharma at September 30, 2022","datePublished":"2022-09-30T20:03:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\/"},"wordCount":431,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc0ODQyNiM0MDEzOTQ2MjUjMjAwMTcwMQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\/","name":"Total number of shares and voting rights in Zealand Pharma at September 30, 2022 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc0ODQyNiM0MDEzOTQ2MjUjMjAwMTcwMQ==","datePublished":"2022-09-30T20:03:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc0ODQyNiM0MDEzOTQ2MjUjMjAwMTcwMQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc0ODQyNiM0MDEzOTQ2MjUjMjAwMTcwMQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Total number of shares and voting rights in Zealand Pharma at September 30, 2022"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/690826","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=690826"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/690826\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=690826"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=690826"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=690826"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}